BOSTON--(BUSINESS WIRE)--Decibel Therapeutics, a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, ...
– Program to screen for congenital, monogenic hearing loss in children diagnosed with auditory neuropathy – “We are pleased to collaborate with Invitae to introduce AmplifyTM, which is designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback